基本信息
浏览量:1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
Currently, I am working as a post-doctoral fellow at the Department of Immunology and Microbiology, University of Texas Rio Grande Valley, Texas, USA, aiming to understand the biology of the Ribosome biogenesis (RiBi) and to develop therapeutic regimens against pancreatic and hepatocellular carcinoma via targeting the RiBi, particularly the RNA pol-I activity and ribosomal proteins (RPs) i.e., RPA135, RPS20, and RPL6. Before moving to USA, I worked as a Young Scientist Fellow and Principal Investigator (PI) as I was awarded with the prestigious Young Scientist Fellowship in 2019 by the Department of Health Research (DHR), Ministry of Health & Family Welfare (MoHFW), Govt. of India. During this tenure, I particularly focused on cardiovascular pharmacology via targeting the proprotein convertase subtilisin Kexin/type-9 (PCSK-9) and 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-R) as it is quite imperative to develop novel therapeutic agents in order to regulate cholesterol homeostasis.
研究兴趣
论文共 28 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CLINICAL LABORATORYno. 2 (2024): 286-295
INDIAN JOURNAL OF PHARMACEUTICAL SCIENCESno. 1 (2023): 176-188
International journal of molecular sciencesno. 8 (2023): 7336-7336
Intelligent Pharmacy (2023)
EXCLI JOURNAL (2022): 47-76
Revista Brasileira de Farmacognosiano. 6 (2022): 962-973
Pharmacological Research - Modern Chinese Medicine (2022): 100184
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn